RWM
NVS icon

Rench Wealth Management’s Novartis NVS Stock Holding History

Rench Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-33,106
Closed -$3.13M – 42
2019
Q4 		$3.13M Buy
33,106
+966
+3% +$86.7K 1.81% 27
2019
Q3 		$2.79M Buy
32,140
+1,376
+4% +$124K 1.81% 29
2019
Q2 		$2.81M Sell
30,764
-3,639
-11% -$308K 1.8% 30
2019
Q1 		$2.96M Buy
34,403
+340
+1% +$27.3K 1.94% 26
2018
Q4 		$2.62M Buy
34,063
+351
+1% +$27.3K 1.92% 27
2018
Q3 		$2.6M Buy
33,712
+166
+0.5% +$12.3K 1.74% 29
2018
Q2 		$2.27M Sell
33,546
-668
-2% -$46.1K 1.64% 33
2018
Q1 		$2.48M Sell
34,214
-1,010
-3% -$76.9K 1.69% 30
2017
Q4 		$2.65M Buy
35,224
+2,235
+7% +$169K 1.72% 29
2017
Q3 		$2.54M Buy
32,989
+2,412
+8% +$182K 1.75% 28
2017
Q2 		$2.29M Sell
30,577
-159
-0.5% -$11.3K 1.69% 30
2017
Q1 		$2.04M Buy
30,736
+446
+1% +$29.7K 1.52% 33
2016
Q4 		$1.98M Buy
30,290
+1,569
+5% +$102K 1.57% 31
2016
Q3 		$2.03M Sell
28,721
-17,668
-38% -$1.29M 1.64% 30
2016
Q2 		$3.43M Buy
46,389
+3,108
+7% +$215K 2.77% 19
2016
Q1 		$2.81M Buy
43,281
+1,567
+4% +$107K 2.31% 23
2015
Q4 		$3.22M Buy
41,714
+180
+0.4% +$14.3K 2.77% 16
2015
Q3 		$3.42M Sell
41,534
-57
-0.1% -$5.07K 3.14% 15
2015
Q2 		$3.67M Sell
41,591
-1,718
-4% -$158K 3.2% 14
2015
Q1 		$3.83M Sell
43,309
-1,266
-3% -$112K 3.28% 15
2014
Q4 		$3.7M Sell
44,575
-1,136
-2% -$94.2K 3.11% 15
2014
Q3 		$3.86M Buy
45,711
+753
+2% +$60.9K 3.29% 12
2014
Q2 		$3.65M Buy
44,958
+2,042
+5% +$161K 3.18% 16
2014
Q1 		$3.27M Buy
42,916
+24,023
+127% +$1.75M 3.1% 16
2013
Q4 		$1.36M Buy
+18,893
New +$1.31M 1.32% 28

Other funds holding NVS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rench Wealth Management's NVS Position: Q1 2020 in Review

Rench Wealth Management sold out of Novartis (NVS) in Q1 2020, closing a stake of 33,106 shares — an estimated $3.13M sold.

Rench Wealth Management first reported a position in NVS in Q4 2013 and held it in 25 quarters. The position peaked at $3.86M in Q3 2014. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

  • Rench Wealth Management reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
  • Rench Wealth Management sold 33,106 Novartis shares in Q1 2020, an estimated $3.13M.
  • Rench Wealth Management first reported a position in Novartis in Q4 2013 and held it in 25 quarters.
  • Rench Wealth Management's Novartis position peaked at $3.86M in Q3 2014.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Rench Wealth Management's 13F filing for Q1 2020, filed 14 May 2020.